Dear Students and Families,
This morning, the Centers for Disease Control and Prevention (CDC) recommended a temporary suspension of the Johnson & Johnson (Janssen) COVID-19 vaccine. This news follows reports of a very rare blood-clotting side effect discovered in six women in the United States, among more than 6.8 million administered doses.
Adelphi University continues to follow the guidance of the CDC and New York state. Based on our commitment to the health, safety and well-being of our students, all appointments for Johnson & Johnson vaccines will be paused until further notice while health and safety agencies evaluate next steps. On-campus vaccination appointments for students will resume when and if it is deemed safe to do so.
Those who have already received the Johnson & Johnson vaccine should follow his guidance from the CDC and the U.S. Food and Drug Administration (FDA). Symptoms to look for include:
- Severe headaches
- Abdominal pain
- Leg pain
- Shortness of breath
If you experience any of the above symptoms within three weeks after vaccination, be sure to contact your healthcare provider immediately. You may also contact our Health Services Center, by email at healthservicescenter@adelphi.edu or by phone at 516.877.6002, with questions, concerns or to report symptoms.
Thank you for your continued diligence in protecting the health and safety of our community.
Sincerely,
Nicole Gaudino
Executive Director
University Health and Wellness